No results for ‘’
Zydus Lifesciences Ltd
₹1126.80
(1.05%)
Wed, 05 Aug 2026, 00:53 am
Health Technology
Pharmaceuticals: Major
24.5KZydus Lifesciences Share Price Live Chart
1 Day
(1.05%)
No Result Found
Summary
Market Cap (in Cr)
108441.84
Net Profit (in Cr)
4614.8
P/B
3.72
Sector P/E
33.76
P/E
19.69
EV/EBITDA
12.57
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
21.08
ROCE
24.56
Debt/Equity
0.09
EPS (TTM)
53.99
Dividend Yield
0.09
Book Value
269.43
Interest Cover
37.33
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (3.5x coverage).
- Dividends after 3 years are expected to be well covered by earnings (4.8x coverage).
- Dividends per share have been stable in the past 10 years.
- Cadila Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Cadila Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Cadila Healthcare is expected to decrease over the next 2 years.
- Cadila Healthcare's net income is expected to increase but not above the 50% threshold in 2 years time.
- Cadila Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
- Cadila Healthcare's revenue is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 75.00 | 75.00 | 74.99 | 74.99 | 74.99 |
| FII | 6.95 | 7.06 | 7.34 | 7.13 | 7.32 |
| DII | 11.20 | 11.09 | 10.86 | 11.13 | 11.01 |
| Public | 6.85 | 6.85 | 6.80 | 6.74 | 6.68 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1307.27 | 1220.87 | 1173.83 | 1134.47 | 1087.43 | 1048.07 | 961.67 |
| Fibonacci | 1220.87 | 1187.86 | 1167.47 | 1134.47 | 1101.46 | 1081.07 | 1048.07 |
| Camarilla | 1150.56 | 1142.64 | 1134.72 | 1134.47 | 1118.88 | 1110.96 | 1103.04 |
Pivots Level: Classic
R3
+172.80
1307.27
R2
+86.40
1220.87
R1
+39.37
1173.83
S1
-47.03
1087.43
S2
-86.40
1048.07
S3
-172.80
961.67
Moving Average
Period
Value
10-EMA
1123.08
20-EMA
1123.05
30-EMA
1116.74
50-EMA
1095.36
100-EMA
1047.72
200-EMA
1005.05
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 19 May 2026 | board-meetings | Quarterly Results, Final Dividend | |
| 19 May 2026 | dividend | ₹1.00 Dividend /Share | 24 Jul 2026 |
| 19 May 2026 | buyback | ||
| 19 May 2026 | agm | ||
| 09 Feb 2026 | board-meetings | Quarterly Results | |
| 06 Nov 2025 | board-meetings | Quarterly Results | |
| 25 Jun 2025 | dividend | Final Dividend - Rs. - 11 | 25 Jul 2025 |
| 20 May 2025 | agm | ||
| 19 May 2025 | dividend | ₹11.00 Dividend /Share | 25 Jul 2025 |
| 26 Jun 2024 | dividend | Final Dividend - Rs. - 3 | 26 Jul 2024 |
Peer Comparison
Zydus Lifesciences Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Zydus Lifesciences Ltd About
Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.(Source : 202503-Annual Report Page No:291)
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1995
Headquarters
CEO
Pankaj R Patel
Employees
Contact
Website
http://www.zyduscadila.com
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila.
Phone
91-079-26868100
Location
Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad, Gujarat, 382481
Zydus Lifesciences Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| UBS PRINCIPAL CAPITAL ASIA LIMITED | bulk | Sell | 6701664 | 1128.11 | 30 Aug 2024 |
| INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD. | bulk | Buy | 5460159 | 258.21 | 28 May 2019 |
| BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF | bulk | Buy | 7102797 | 403 | 30 Nov 2015 |
| BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF | bulk | Sell | 555000 | 402.79 | 30 Nov 2015 |
| BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD | block | Sell | 4604326 | 427.75 | 27 Oct 2015 |
| BARCLAYS MERCHANT BANK (SINGAPORE) LTD | block | Buy | 4604326 | 427.75 | 27 Oct 2015 |
| BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD | block | Sell | 2169720 | 435.5 | 20 Oct 2015 |
| BARCLAYS MERCHANT BANK (SINGAPORE) LTD | block | Buy | 2169720 | 435.5 | 20 Oct 2015 |
| BARCLAYS MERCHANT BANK (SINGAPORE) LTD | block | Buy | 1559839 | 424 | 14 Oct 2015 |
| BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD | block | Sell | 1559839 | 424 | 14 Oct 2015 |
Frequently Asked Questions
1.What is the stock price of Zydus Lifesciences Ltd?
As of 05/08/2026 at 6:23 AM, Zydus Lifesciences Ltd shares are trading at ₹1126.80.
2.What is the market cap. of Zydus Lifesciences Ltd?
As of 05/08/2026, the market capitalization of Zydus Lifesciences Ltd is ₹1,12,368.80 crore.
3.When was Zydus Lifesciences Ltd founded?
Zydus Lifesciences Ltd was founded in 1995.
4.What are the P/E and P/B ratios of Zydus Lifesciences Ltd?
As of 05/08/2026, Zydus Lifesciences Ltd has a P/E ratio of 22.50 and a P/B ratio of 3.72.
5.How can I buy shares of Zydus Lifesciences Ltd?
You can buy shares of Zydus Lifesciences Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Zydus Lifesciences Ltd?
As of March,2026, promoters hold 75.00% in Zydus Lifesciences Ltd, while FIIs, DIIs and public shareholders hold 6.95%, 11.20% and 6.85%, respectively. The government holds 0.00%.
7.Does Zydus Lifesciences Ltd pay dividends?
Yes, Zydus Lifesciences Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹1.00 Dividend /Share per share.
8.What is the dividend yield of Zydus Lifesciences Ltd?
As of 05 August, 2026, the dividend yield of Zydus Lifesciences Ltd stands at 0.09%.
9.What are the latest financial results of Zydus Lifesciences Ltd?
For January,2024, Zydus Lifesciences Ltd reported revenue of ₹22,857.00 crore and a net profit of ₹4,526.00 crore.
10.What is the Stock symbol of Zydus Lifesciences Ltd?
ZYDUSLIFE is the stock symbol of Zydus Lifesciences Ltd.
11.Who is the CEO of Zydus Lifesciences Ltd?
The CEO of Zydus Lifesciences Ltd is Pankaj R Patel.